Vorinostat
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3329 publications
A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latency.
Journal: mBio
Published: June 15, 2026
Metric analysis of molecular graphs of selected anticancer drugs.
Journal: Future medicinal chemistry
Published: June 13, 2026
An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates.
Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026
Histone decrotonylation plays a distinct role in HIV latency.
Journal: Science advances
Published: April 10, 2026
Hypophosphatemia as a Potential Class Effect of Histone Deacetylase Inhibitors: Evidence from Disproportionality Analysis and Mendelian Randomization Analysis of Drug Targets.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026
Editor's Note: Antitumor Activity of Suberoylanilide Hydroxamic Acid against Thyroid Cancer Cell Lines In vitro and In vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 27, 2026
Latent HIV Reservoirs in the Central Nervous System: Mechanisms, Barriers, and Therapeutic Approaches.
Journal: ACS infectious diseases
Published: March 26, 2026
Efficacy and Safety of Mogamulizumab for Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 01, 2026
A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of Lymphoma.
Journal: Journal of medicinal chemistry
Published: March 01, 2026
Last Updated: 06/30/2026